Fin Cascade
Get Android appGet iOS app

Prices as of 9 Oct 2026 close · Not investment advice

Balaji Amines Limited

NSE: BALAMINESSpecialty Chemicals

Share price

₹2,040.80

-2.14% close of 9 Oct 2026

Market cap ₹6,122 CrP/E 30.0

Price-based ratios (P/B, dividend yield, EV/EBITDA) are as of 7 Oct 2026, the close above is 9 Oct 2026.

Business score

How strong the business is, in one number. The parts behind it are in Pro.

57

out of 100 · worked out 9 Oct 2026

How the business score works

Your ratios

The numbers you want to see first. Tap Edit to change them.

Market cap

₹6,122 Cr

P/E ratio

30.0

P/B ratio

3.3

ROCE

11.0%

ROE

8.7%

Dividend yield

0.5%

Price & valuation chart

How the share price and its valuation have moved. Hover over the chart to see any day. Prices as of the last close.

Prices as of 9 Oct 2026 close52-week high ₹2,566.8052-week low ₹977.20

Answers

Simple answers to the questions investors ask most, from the company's own numbers.

How fast it has been growing

Sales grew 11.1% over the past year, and 13.9% a year over its longer record. Meanwhile what it keeps of every 100 rupees of sales slipped from 27.4% to 21.0% over the last four years.

Whether it grew faster than its sector

It grew 13.9% a year against a sector median of 10.2% — 3.7 percentage points faster.

Room to re-rate, or risk of de-rating

At 30.0× earnings against a market that pays 24.1× across 2199 companies we can price. Its own industry sits at 57.1×, across 5 companies. It is against its own five-year median of 26.8×, the 67th percentile of its own range.

Whether growth justifies the valuation

Its earnings are falling, so growth cannot justify the price.

Profit growthPrice per ₹1 profitPer 1% growth
Balaji Amines Limited — this one-20%/yr30.0×—
Pidilite Industries25%/yr57.1×₹2.3
Gujarat Fluorochemicals Limited-24%/yr79.7×—
Navin Fluorine International Limited21%/yr52.6×₹2.5
Aether Industries Limited20%/yr96.9×₹4.8
Deepak Nitrite Limited-13%/yr27.6×—

Compared with companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

How it compares with its peers

Against companies the exchange files under the same label (Specialty Chemicals), it ranks 38 of 73 on returns, 24 of 72 on growth, 20 of 73 on margin. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

What makes it hard to beat — and is that still true?

No durable advantage shows in the numbers: it earns 11% on capital, ahead of 48% of companies filed under the same label. That grouping comes from the exchange's filing category, so some of them may not be real rivals.

Whether its growth pays for itself

Yes — Over the last five years it made ₹1347 crore of cash from the business, spent ₹1069 crore on plant and equipment, and returned ₹177 crore to lenders and shareholders. And the profit is real: of every 100 rupees it reported over 12 years, about 96 arrived as cash. Its cash comes back faster than it used to: it went from being waiting 88 days for its cash to waiting 69 days for its cash.

Profit reality check

Is the profit real cash? Simple checks on the accounts. Facts only, not advice.

7 of 10 checks clear · 70%

How the profit check works

Latest result

What the last results showed. Whether management kept its word is in Pro.

Results are expected soon.

Checklist before you investPRO

Points for and against, in one list.

Key numbers & peers

The main numbers grouped by topic, and how the company compares with similar ones.

Price

Market cap
₹6,122 Cr
Prev close
₹2,040.80
52w High
₹2,630
52w Low
₹968
Enterprise value
₹5,984 Cr
Beta
1.4
Price CAGR 1y
55.0%
Price CAGR 3y
-1.0%
Price CAGR 5y
-14.0%
Price CAGR 10y
21.0%

Ratios

Return on assets
6.2%
PEG ratio
-1.6
P/E ratio
30.0
P/B ratio
3.3
EV / EBITDA
18.3
Industry P/E
31.9
ROCE
11.0%
ROCE 5y average
24.8%
ROE
8.7%
Debt / Equity
0.1
Interest coverage
47.4
Dividend yield
0.5%
ROE 3y average
10.0%
ROE last year
9.0%

Annual P&L

Annual revenue
₹1,419 Cr
Annual profit
₹169 Cr
Operating margin
19.0%
Net profit margin
11.9%
EBITDA margin
18.7%
Sales growth 3y
-15.4%
Sales growth 5y
1.6%
Profit growth 3y
-20.0%
Profit growth 5y
-7.0%
EPS
₹51.6
Sales growth TTM
11.0%
Profit growth TTM
34.0%
Dividend payout
21.0%

Quarter P&L

Sales latest quarter
₹456 Cr
Profit latest quarter
₹78 Cr
YoY quarterly sales growth
27.2%
YoY quarterly profit growth
110.8%
OPM latest quarter
25.4%

Balance Sheet

Book Value
₹659
Face Value
₹2.0
Total debt
₹133 Cr
Total cash
₹271 Cr
Borrowings
₹133 Cr
Reserves / Equity
328.3

Cash Flow

Operating cash flow
₹184 Cr
Free cash flow
-₹179 Cr
FCF yield
-3.0%
Net cash flow
-₹75 Cr

Shareholding

Promoter holding
54.6%
FII holding
3.2%
DII holding
1.6%
Public holding
40.7%

Peer comparison

CompanyPrice ₹P/EMkt cap ₹ CrDiv yield %Profit qtr ₹ CrProfit var %Sales qtr ₹ CrSales var %ROCE %
Pidilite Inds.1,488.5057.31,51,6850.77883.528.24,551.621.331.0
Gujarat Fluoroch4,555.9080.849,8930.07219.021.41,588.024.09.6
Navin Fluo.Intl.8,490.0054.843,5450.18243.3107.71,045.144.121.0
Aether Industri.1,787.6098.923,7240.0062.828.0326.627.311.9
Deepak Nitrite1,553.9026.821,1980.48345.0207.52,577.636.411.4
Aarti Industries491.2534.217,8420.20155.0256.52,387.042.56.9
Atul5,999.5022.217,6600.50253.992.01,848.025.014.9
Balaji Amines2,155.9034.26,9840.5178.197.2455.927.211.0
Median367.3029.71,0980.2413.552.2175.326.413.8

Competes with: Aarti Industries Limited, Aether Industries Limited, Atul Limited, BASF India Limited, Deepak Nitrite Limited, Gujarat Fluorochemicals Limited, Navin Fluorine International Limited, Pidilite Industries

Quarterly results

Sales and profit for each of the last 13 quarters. Newest on the right. ₹ crore.

Consolidated · to 30 Jun 2026
Line itemJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales464381383414385347313353358341331395456
Expenses366327309316319286267293304281275301340
Material Cost166175244231246
Change in Inventories4610.00-61-106.89
Purchases of Stock-in-Trade00000
Employee Cost2019182626
Other Expenses7176735361
Operating Profit985474986661466055605794116
OPM %21141924171715171518172425
Other Income6789898897586
Exceptional items (within Other Income)00000
Interest2221111111221
Depreciation11111112121212131414141414
Profit before tax904870936257415449524686106
Tax %25242122262724252528332526
Net Profit68365672464131403737316578
EPS in Rs161115211313101212119.702023
Diluted EPS in Rs12119.492023

Profit & loss

Yearly sales, costs and profit for 12 years, plus the last 12 months (TTM). ₹ crore.

Consolidated · to 31 Mar 2026
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales6166406688589409351,3082,3142,3461,6311,3971,4251,523
Expenses5155145196767477549351,6911,7361,3081,1571,1541,196
Material Cost811
Change in Inventories-15
Purchases of Stock-in-Trade0
Employee Cost84
Other Expenses279
Operating Profit102127149182193181373623609324232265327
OPM %17202221211929272620171921
Other Income43912456151530332925
Exceptional items (within Other Income)0
Interest35221391323181712645.376
Depreciation20192019203234424645485656
Profit before tax5188126166165131327578567302213232290
Tax %353434322926252828232627
Net Profit33588211311797243418406232159169211
EPS in Rs1018253536327411410063495263
Diluted EPS in Rs52
Dividend Payout %1211978105510172321

Compounded growth

Average yearly growth over different spans, as stored. A span can cross a demerger or an acquisition.

Compounded sales growth

10 years
8%
5 years
2%
3 years
-15%
TTM
11%

Compounded profit growth

10 years
11%
5 years
-7%
3 years
-20%
TTM
34%

Stock price CAGR

10 years
21%
5 years
-14%
3 years
-1%
1 year
55%

Return on equity

10 years
18%
5 years
16%
3 years
10%
Last year
9%

Balance sheet

What the company owns and what it owes, at the end of each year. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital66666666666.486.48
Reserves2212743564615686528881,2431,5481,7151,8391,970
Borrowings256173105152227260127101582011133
Other Liabilities139152168229244195289395351405396633
Minority Interest175
Total Liabilities6236056358481,0461,1131,3101,7451,9632,1462,2522,743
Fixed Assets3413413253163205735436817808961,0031,043
CWIP3162512326946173141113205238512
Investments00000480073000
Other Assets2782482844094574465949239961,0461,0111,188
Total Assets6236056358481,0461,1131,3101,7451,9632,1462,2522,743

Cash flows

Real money coming in and going out each year — from the business, from investments and from loans. ₹ crore.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity56856014094144110220354334255184
Cash from Investing Activity-4-29-10-135-119-130-62-147-210-274-139-344
Cash from Financing Activity-55-54-551621-26-37-57-81-75-4985
Net Cash Flow-32-521-4-12111663-1568-75
Free Cash Flow48534732-7583-21722348269-179

Ratios

How fast customers pay, how long stock sits, and how well capital earns — year by year.

Consolidated
Line itemMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days717168736581859359717289
Inventory Days114801067011677646689116128113
Days Payable485855566042445418313239
Cash Conversion Cycle1369311987120116104105129156168163
Working Capital Days7124231475588888911412069
ROCE %182330322418354936171111

Shareholding pattern

Who owns the company — founders (promoters), foreign funds, Indian funds and the public. In %.

Consolidated · to 30 Jun 2026
Line itemSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters545454545454555555555555
FIIs4.524.584.925.055.275.165.0954.533.302.993.17
DIIs0.901.431.481.591.791.661.481.461.521.531.461.58
Public414040403939393939414141
No. of Shareholders1,44,9901,41,4171,38,0171,32,4281,29,1601,29,3611,27,4421,21,9501,18,8941,17,5911,15,7541,11,615

Price trend

The price as a Renko brick chart: small moves drop out so the bigger path stands out.

Change over 1 year +49.1% (₹1,368.50 → ₹2,040.80)Brick size ₹121.22 (fixed)Bricks 22
₹1,000₹1,500₹2,500₹2,041Dec '25May '26Aug '26
Price moved up one brickPrice moved down one brickLast close ₹2,040.80 on 9 Oct 2026

Every brick is the same size, about one typical day's move. A new brick needs a full brick's move; turning the other way needs two. Bricks show where the price went, not where it will go.

Open interestPRO

Where option traders are positioned on this stock.

Industry numbers

The numbers that matter most in this industry, from the company's own filings.

1 when an audit qualification is filed as repetitive

0.00flag

2026-03-31

the company's own unlisted debt securities in default at period end

0.00cr

2026-06-30

the company's own loans / revolving facilities in default at period end (standalone filing)

0.00cr

2026-06-30

net debt from the filed balance sheet at the newest year end: Borrowings − Cash Equivalents − Investments (Current); negative = net cash

-138inr_cr

2026-03-31

guarantees / comfort given for promoter, promoter group, directors and KMP

0.00cr

2026-03-31

loans outstanding to promoter, promoter group, directors and KMP (governance filing)

0.00cr

2026-03-31

security given for the borrowing of promoter, promoter group, directors and KMP

0.00cr

2026-03-31

FY revenue / permanent employees + workers, same basis (calc)

1,11,24,416inr

2026-03-31

News

News and filings about Balaji Amines Limited. Open one to see why it matters.

Supply chain

Who it buys from, sells to and competes with — as recorded in our map of company links.

Competes with

Uses as raw material

  • acetic acid
  • acetone
  • ammonia (primary feedstock for amines)
  • butanediol
  • butyl alcohol / butanol
  • denatured ethyl alcohol / ethanol (feedstock for ethylamines)
  • diethylene glycol
  • ethylene oxide
  • methanol (primary feedstock for methylamines)
  • monoethanolamine (MEA) - bought intermediate (price highly volatile)

Sells to

  • Hetero Drugs · aliphatic amines, amine derivatives and specialty chemicals (pharma intermediates/solvents…
  • Kores India Limited · amines and specialty chemicals
  • Teva API · amines and specialty chemical intermediates for API manufacture

About

What the company is, from our own records: where it sits, where it makes things, and what it is made of.

Sector
Chemicals
Industry
Specialty Chemicals
Classification
Chemicals › Specialty Chemicals
ISIN
INE050E01027

Business segments

  • Amines & Speciality Chemicals · 98%
  • Hotel Division · 3%

Plants

  • Balaji Amines Unit I (Tamalwadi, Solapur)
  • Balaji Amines Unit II (Solapur)
  • Balaji Amines Unit III (Solapur)
  • Balaji Amines Unit IV (Solapur) - DME / new products
  • Balaji Amines Unit V (Solapur)
  • Balaji Amines captive solar power plant
  • Balaji Speciality Chemicals unit (subsidiary)

News impact

Big market events that reach Balaji Amines Limited, and how the effect spreads.

No recent market events reach this company.

Dividends, splits & big trades

Money paid out, share splits and buybacks, and big buys or sells by funds and insiders.

Dividends

3 Jul 2026unspecified₹11
1 Aug 2025unspecified₹11
4 Jul 2024unspecified₹11
3 Jul 2023unspecified₹10
21 Jun 2022unspecified₹6
29 Jul 2021unspecified₹4
30 Jul 2020unspecified₹0.6
17 Mar 2020interim₹2.6

Splits, bonuses & buybacks

  • daily-prices repair: 9 rows from NSE's archive (replace 1, delete 1, insert 7), 2016-10-30..2026-02-01 (docs/flat_day_repair.md)1× · 30 Oct 2016

Documents

Annual reports, results presentations and earnings calls, straight from the source.

Facts from company filings and exchange data. Not investment advice: nothing here tells you to buy or sell.